Genaera Corporation
(NASDAQ:GENR)|
0.51 +0.08 (18.60%) Dec 01 - Close |
|
|
|
- Compare GENR with:
- View: Line | Candlestick
Company Profile
Genaera Corporation
5110 Campus Drive
Plymouth Meeting, PA 19462
United States - Map
Phone: (610) 941-4020
Fax: (610) 941-5399
Website: www.genaera.com
State of incorporation: Delaware
CEO: John L. Armstrong, Jr.
Employees: 24
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Res/dev therapeutic products
A biopharmaceutical company committed to developing medicines to address the unmet medical needs in pharmaceutical markets.
Recent news for GENR
-
GENAERA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - 16 hours ago
-
Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
PR Newswire - 18 hours ago
-
EDGAR Online Financials - Nov 21 at 9:04 ET
-
New Star Analyst Rankings for Genaera Corporation
StarMine - Nov 17 at 9:23 ET
-
EDGAR Online - Nov 14 at 12:31 ET
-
Genaera Corporation Announces Third Quarter Financial Results
PR Newswire - Nov 14 at 9:52 ET
-
GENAERA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - Nov 13 at 4:09 ET
-
Genaera to Present at BIO-Europe 2008
PR Newswire - Nov 13 at 10:47 ET
-
GENAERA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - Nov 06 at 3:29 ET
-
Genaera to Present at the Rodman & Renshaw Healthcare Conference
PR Newswire - Nov 06 at 8:00 ET